NVE (NVEC) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
The 2025 Annual Meeting of Shareholders is scheduled for August 7, 2025, with proxy materials available online and by mail.
Shareholders will vote on the election of five directors, an advisory resolution on executive compensation, and the ratification of the independent auditor.
The company reported strong profitability in fiscal 2025 despite an industry downturn, with $16.0 million in operating income and a 39% total shareholder return over three years.
Voting matters and shareholder proposals
Shareholders will vote on electing five incumbent directors, approving executive compensation, and ratifying Boulay PLLP as the independent auditor for fiscal 2026.
No shareholder proposals or nominations were received for this meeting.
Shareholders of record as of June 13, 2025, are eligible to vote, with each share entitled to one vote.
Board of directors and corporate governance
The board consists of five directors, including an independent chairman and the CEO, with a focus on diversity, experience, and independence.
Board committees (Audit, Compensation, Nominating/Corporate Governance) are composed solely of independent directors.
The board conducts annual self-evaluations and reviews CEO succession planning at least annually.
Board refreshment is encouraged through evaluation and compensation policies, though no age or term limits are imposed.
Latest events from NVE
- Quarterly revenue rose 23% and net income 11% year-over-year, with a $1.00 dividend declared.NVEC
Q3 20263 Feb 2026 - Revenue and net income declined, but gross margin and cash returns to shareholders remained strong.NVEC
Q1 20253 Feb 2026 - Gross margin rose to 86% as R&D revenue surged and a $1.00 dividend was declared.NVEC
Q2 202519 Jan 2026 - Revenue and net income fell, but gross margin improved to 84% and a dividend was declared.NVEC
Q3 20259 Jan 2026 - Maintained strong earnings, expanded R&D, and appointed a new director with medical expertise.NVEC
Proxy Filing1 Dec 2025 - Annual meeting to elect directors, approve pay, and ratify auditor, with focus on ESG and governance.NVEC
Proxy Filing1 Dec 2025 - Annual Meeting to vote on directors, executive pay, and auditor ratification August 1, 2024.NVEC
Proxy Filing1 Dec 2025 - Shareholders receive updated proxy materials and online access for upcoming governance votes.NVEC
Proxy Filing1 Dec 2025 - Strong earnings, R&D investment, and 39% shareholder return highlight a year of innovation and growth.NVEC
Proxy Filing1 Dec 2025